companydata.dkcompanydata.dk

Rinascibella Group ApS: Financial statements 2022

CVR: 29316082

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Rinascibella Group ApS (CVR 29316082) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -22,492 and a net result of DKK -23,460 compared with DKK -292,405 the year before. Equity in the 2022 report amounted to DKK -3,355.

Gross Profit
DKK -22,492
Profit/Loss
DKK -23,460
Equity
DKK -3,355
Total Assets
DKK 25,739
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--22 t.-23 t.-3 t.0
202118 t.-285 t.-292 t.20 t.-
2020152 t.39 t.-14 t.313 t.-
2019232 t.141 t.90 t.327 t.0
2018312 t.107 t.55 t.237 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Rinascibella Group ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Rinascibella Group ApS: The 2021 annual report is outJul 12, 2022

Rinascibella Group ApS has published its annual report for 2021. Revenue came to DKK 17,867, and the net result was DKK -292,405.

About Rinascibella Group ApS

Rinascibella Group ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MAKKY INVEST ApS. The management consists of Mehrdad Makky. The company is owned by MAKKY HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,149 and a net result of DKK -6,061 compared with DKK 24,225 the year before. Equity in the 2025 report amounted to DKK 10,599.

Source: annual report 2025, Danish Business Authority